Richard Newitter
Stock Analyst at Truist Financial
(4.02)
# 1,652
Out of 4,429 analysts
985
Total ratings
46.5%
Success rate
5.1%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRDN Guardian Pharmacy Services | Reiterated: Buy | $47 | $42.41 | +10.82% | 1 | Jun 17, 2026 | |
| EW Edwards Lifesciences | Maintained: Hold | n/a | $87.36 | - | 39 | Jun 16, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | n/a | $104.65 | - | 32 | Jun 16, 2026 | |
| PODD Insulet | Reiterated: Buy | $219 | $145.76 | +50.25% | 14 | Jun 12, 2026 | |
| BSX Boston Scientific | Rated: Buy | $64 | $45.29 | +41.31% | 50 | Jun 4, 2026 | |
| MDT Medtronic | Rated: Hold | $86 | $79.34 | +8.39% | 48 | Jun 4, 2026 | |
| GKOS Glaukos | Maintained: Buy | n/a | $130.68 | - | 22 | May 29, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | n/a | $103.86 | - | 56 | May 26, 2026 | |
| BBNX Beta Bionics | Maintained: Buy | n/a | $13.88 | - | 12 | May 22, 2026 | |
| DXCM DexCom | Reiterated: Buy | n/a | $72.47 | - | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $15.84 | +13.64% | 15 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $4.19 | -52.27% | 35 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $31 | $15.30 | +102.61% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $40.10 | - | 17 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $79.23 | - | 54 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.07 | +78.75% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $64 → $50 | $42.61 | +17.34% | 65 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 | $307.80 | +7.21% | 48 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $90.96 | - | 17 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $21.72 | - | 38 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $92 | $87.97 | +4.58% | 69 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 | $406.78 | +42.58% | 72 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $12 | $17.58 | -31.74% | 35 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $135 | $127.00 | +6.30% | 66 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $18.87 | +5.99% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $317.20 | +17.91% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $43.03 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $90.43 | - | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.39 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $224.66 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $10.65 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.08 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $148 | $160.60 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $2.44 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $4.73 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 57.30 → CHF 66.18 | $52.86 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $127.06 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $143.98 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $44.84 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.73 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $182.08 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $32.58 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $88.41 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $28.80 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $19.89 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $228.39 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $6.74 | n/a | 1 | Jul 15, 2016 |
Guardian Pharmacy Services
Jun 17, 2026
Reiterated: Buy
Price Target: $47
Current: $42.41
Upside: +10.82%
Edwards Lifesciences
Jun 16, 2026
Maintained: Hold
Price Target: n/a
Current: $87.36
Upside: -
iRhythm Holdings
Jun 16, 2026
Maintained: Buy
Price Target: n/a
Current: $104.65
Upside: -
Insulet
Jun 12, 2026
Reiterated: Buy
Price Target: $219
Current: $145.76
Upside: +50.25%
Boston Scientific
Jun 4, 2026
Rated: Buy
Price Target: $64
Current: $45.29
Upside: +41.31%
Medtronic
Jun 4, 2026
Rated: Hold
Price Target: $86
Current: $79.34
Upside: +8.39%
Glaukos
May 29, 2026
Maintained: Buy
Price Target: n/a
Current: $130.68
Upside: -
Lantheus Holdings
May 26, 2026
Maintained: Buy
Price Target: n/a
Current: $103.86
Upside: -
Beta Bionics
May 22, 2026
Maintained: Buy
Price Target: n/a
Current: $13.88
Upside: -
DexCom
May 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $72.47
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: $20 → $18
Current: $15.84
Upside: +13.64%
May 12, 2026
Reiterated: Hold
Price Target: $2
Current: $4.19
Upside: -52.27%
May 11, 2026
Reiterated: Buy
Price Target: $35 → $31
Current: $15.30
Upside: +102.61%
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $40.10
Upside: -
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $79.23
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $18
Current: $10.07
Upside: +78.75%
May 5, 2026
Maintained: Hold
Price Target: $64 → $50
Current: $42.61
Upside: +17.34%
May 4, 2026
Reiterated: Hold
Price Target: $330
Current: $307.80
Upside: +7.21%
May 1, 2026
Maintained: Buy
Price Target: n/a
Current: $90.96
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $21.72
Upside: -
Apr 29, 2026
Reiterated: Hold
Price Target: $92
Current: $87.97
Upside: +4.58%
Apr 22, 2026
Reiterated: Buy
Price Target: $580
Current: $406.78
Upside: +42.58%
Apr 15, 2026
Maintained: Hold
Price Target: $13 → $12
Current: $17.58
Upside: -31.74%
Mar 4, 2026
Reiterated: Hold
Price Target: $135
Current: $127.00
Upside: +6.30%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $18.87
Upside: +5.99%
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $317.20
Upside: +17.91%
Jan 16, 2026
Maintained: Buy
Price Target: n/a
Current: $43.03
Upside: -
Jun 26, 2025
Maintained: Buy
Price Target: n/a
Current: $90.43
Upside: -
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $25.39
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $224.66
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $10.65
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $26.08
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $148
Current: $160.60
Upside: n/a
Oct 7, 2021
Maintained: Buy
Price Target: n/a
Current: $2.44
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $4.73
Upside: n/a
Aug 17, 2021
Maintained: Hold
Price Target: CHF 57.30 → CHF 66.18
Current: $52.86
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $127.06
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $143.98
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $44.84
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $5.73
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $182.08
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $32.58
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $88.41
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $28.80
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $19.89
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $228.39
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $6.74
Upside: n/a